Fennec Pharmaceuticals Inc. FENC NASDAQ

Fennec Pharmaceuticals Inc. (FENC) reported total assets of $70.07M and total liabilities of $35.02M for quarter ending 2025-12-31, resulting in total equity of $35.05M.

The company held $36.72M in cash and short-term investments. Total debt stood at $0.00, with net debt of $-36.72M. The Debt-to-Equity (D/E) ratio was 0 (conservative).

Current ratio is 6.34, indicating strong short-term liquidity. Interest coverage is -9x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (41/100) — Total assets $70.07M and equity $35.05M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 54/100 with 2/7 criteria passed.